Bucharest

Bucharest is rapidly emerging as a premier life sciences hub in Central and Eastern Europe, distinguished by its robust integration of pharmaceutical manufacturing and cutting-edge healthcare innovation.

The city is home to industry giants like Zentiva, Biofarm and Antibiotice, cementing its reputation as a strategic center for generic drug production and high-capacity pharmaceutical distribution.

Beyond traditional manufacturing, Bucharest’s biotechnology sector is fueled by a surge in deep-tech spin-outs and interdisciplinary research centers such as the eBio-hub at the National University of Science and Technology Politehnica.

The city excels in medical device development, leveraging Romania’s world-class IT talent to pioneer digital health solutions and AI-driven diagnostic tools.

Academic excellence is anchored by the Carol Davila University of Medicine and Pharmacy, which fosters a rich environment for clinical research and translational medicine.

Investment in the ecosystem is accelerating, supported by specialized venture capital firms like Cleverage VC, which focus specifically on healthtech startups and medtech scaling.

Collaborative platforms such as BiomentorHub further bridge the gap between academic research and commercialization, providing mentorship for the next generation of life science leaders.

As a host to numerous international medical conferences in 2026, Bucharest continues to solidify its position as a vital node for global clinical trials and regulatory expertise.

This dynamic ecosystem offers a unique combination of cost-effective R&D infrastructure and a highly skilled scientific workforce, making it an attractive destination for life sciences investment.